These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23224792)

  • 1. Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India.
    Shah A; Javid G; Zargar SA; Teli F; Khan BA; Yattoo GN; Gulzar GM; Sodhi JS; Khan MA; Shoukat A; Saif R
    Indian J Gastroenterol; 2013 Jan; 32(1):32-6. PubMed ID: 23224792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole.
    Giannini EG; Bilardi C; Dulbecco P; Mamone M; Santi ML; Testa R; Mansi C; Savarino V
    J Clin Gastroenterol; 2006 Jul; 40(6):515-20. PubMed ID: 16825934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
    Federico A; Nardone G; Gravina AG; Iovene MR; Miranda A; Compare D; Pilloni PA; Rocco A; Ricciardiello L; Marmo R; Loguercio C; Romano M
    Gastroenterology; 2012 Jul; 143(1):55-61.e1; quize e13-4. PubMed ID: 22484118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?
    O'Connor HJ; Loane J; Bindel H; Bhutta AS; Cunnane K
    Helicobacter; 1997 Dec; 2(4):199-204. PubMed ID: 9421124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):921-6. PubMed ID: 11507356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
    Hassan C; De Francesco V; Zullo A; Scaccianoce G; Piglionica D; Ierardi E; Panella C; Morini S
    Aliment Pharmacol Ther; 2003 Sep; 18(6):641-6. PubMed ID: 12969091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
    Moshkowitz M; Konikoff FM; Peled Y; Brill S; Hallak A; Tiomny E; Santo M; Bujanover Y; Gilat T
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1015-9. PubMed ID: 8971304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
    Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
    Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unhealed duodenal ulcers despite Helicobacter pylori eradication.
    Gisbert JP; Boixeda D; Martín De Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
    Scand J Gastroenterol; 1997 Jul; 32(7):643-50. PubMed ID: 9246702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori.
    Suárez MS; González Cansino J; Velasco Ilizalde C; Sabatier CA; Castillo Hernández J
    Arch Med Res; 1999; 30(1):55-9. PubMed ID: 10071426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
    Gambaro C; Bilardi C; Dulbecco P; Iiritano E; Zentilin P; Mansia C; Usai P; Vigneri S; Savarino V
    Dig Liver Dis; 2003 Nov; 35(11):763-7. PubMed ID: 14674665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
    Choi IJ; Jung HC; Choi KW; Kim JH; Ahn DS; Yang US; Rew JS; Lee SI; Rhee JC; Chung IS; Chung JM; Hong WS
    Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
    De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
    Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
    Boixeda de Miquel D
    Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
    Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.